Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs
Crossref DOI link: https://doi.org/10.1007/s00223-015-0037-y
Published Online: 2015-07-17
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Driessen, Johanna H. M.
van Onzenoort, Hein A. W.
Starup-Linde, Jakob
Henry, Ronald
Burden, Andrea M.
Neef, Cees
van den Bergh, Joop P.
Vestergaard, Peter
de Vries, Frank
License valid from 2015-07-17